| I don’t see how any of this is coming as a surprise to anyone, or even why people are bothering (questionable science behind the choloroquine paper aside, even). This is a comment I posted to HN three weeks ago, when I was pretty sure (but unfortunately wrong!) that the suggested chloroquine dosage for purportedly treating covid-19 was being reported in the wrong units because it was so high, using only the information in the FDA docs on the chloroquines: https://news.ycombinator.com/item?id=22611041 Choloroquine is very well known to have an extremely low therapeutic index (ratio of fatal dosage to effective dosage) and people (well, non-infant children) have been known to die from just a 1g dose. The recommendation for Covid-19 starts at an order of magnitude higher than the recommended FDA dosage for malarial suppression. (Pretty much) everything can kill viruses at high enough doses. The question is if it can do it without killing the patient as well, and it is eminently clear from existing, solid research that choloroquine doesn’t fit that bill. Hydroxychloroquine is better tolerated than chloroquine base, but not that much more to sufficiently matter. It also has its own horrible dangers (including complete blindness from accelerated macular degeneration) that have been well documented at long-term “low” dosages; it is not a stretch to assume they would happen with short term high dosages. There is a reason these only work in vitro - you don’t have to worry about killing the patient there. |